A diffusion longitudinal MR imaging study in normal-appearing white matter in untreated relapsing-remitting multiple sclerosis

American Journal of Neuroradiology

Volumn 28, Issue 3, 2007, Pages 475-478

  Garaci, F G ^a   Colangelo, V ^a   Ludovici, A ^a   Gaudiello, F ^a   Marziali, S ^a   Centonze, D ^a   Boffa, L ^a   Simonetti, G ^a   Floris, R ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; RATING SCALE; RELAPSE; WHITE MATTER;

ADOLESCENT; ADULT; BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; DISABILITY EVALUATION; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVE FIBERS, MYELINATED; RECURRENCE;

EID: 33947580425     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Filippi M. Magnetization transfer imaging to monitor the evolution of individual multiple sclerosis lesions. Neurology 1999;53(Suppl 3):Sl8-22
2. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478-82
3. Filippi M, Arnold DL, Comi G. Magnetic Resonance Spectroscopy in Multiple Sclerosis. Milan, Italy: Springer-Verlag; 2001
4. Ge Y, Grossman RI, Udupa IK, et al. Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2001;22:470-75
5. Cercignani M, Inglese M, Pagani E, et al. Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol 2001;22:952-58
6. Ciccarelli O, Werring DJ, Wheeler-Kingshott CA, et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001;56:926-33
7. Filippi M, Inglese M. Overview of diffusion-weighted magnetic resonance studies in multiple sclerosis. J Neurol Sci 2001;186:537-543
8. Rovaris M, Gass A, Bammer R, et al. Diffusion MRI in multiple sclerosis. Neurology 2005;65:1526-32
9. Caramia F, Pantano P, Di Legge S, et al. A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis. Magn Reson Imaging 2002;20:383-88
10. Cassol E, Ranjeva IP, Ibarrola D, et al. Diffusion tensor imaging in multiple sclerosis: a tool for monitoring changes in normal-appearing white matter. Mult Scler 2004;10:188-96
11. Filippi M, Rocca MA. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol 2005;252 (suppl):v16-v24
12. Miller DH, Thompson AI, Filippi M. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J Neurol 2003;250:1407-19
13. Hafler DA, Slavik IM, Anderson DE, et al. Multiple sclerosis. Immunol Rev 2005;204:208-31
14. Diem R, Hobom M, Maier K, et al. Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway. J Neurosci 2003;23:6993-7000
15. Rao AB, Richert N, Howard T, et al. Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b. Neurology 2002;59:688-94
16. Kraus J, Ling AK, Hamm S, et al. Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro. Ann Neurol 2004;56:192-205
17. Arnon R, Aharoni R. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications. Proc Natl Acad Sci U S A 2004;101(suppl 2):14593-98
18. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31
19. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-27
20. Kurtzke IF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52
21. Griffin CM, Chard DT, Parker GI, et al. The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis. J Neurol 2002;249:193-99
22. Cercignani M, Iannucci G, Rocca MA, et al. Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI. Neurology 2000;54:1139-44
23. Gallo A, Rovaris M, Riva R, et al. Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. Arch Neurol 2005;62:803-08
24. Brainin M, Neuhold A, Reisner T, et al. Changes within the "normal" cerebral white matter of multiple sclerosis patients during acute attacks and during high-dose cortisone therapy assessed by means of quantitative MRI. J Neurol Neurosurg Psychiatry 1989;52:1355-59
25. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004;55:458-68
26. Castriota-Scanderbeg A, Fasano F, Hagberg G, et al. Coefficient D(av) is more sensitive than fractional anisotropy in monitoring progression of irreversible tissue damage in focal nonactive multiple sclerosis lesions. AJNR Am J Neuroradiol 2003;24:663-70
27. Guo AC, MacFall IR, Provenzale IM. Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter. Radiology 2002; 222:729-36